RedHill Biopharma Ltd. Made Big Gain
Thu, Aug 01, 2024 at 07:06 PM
RedHill Biopharma Ltd. (RDHL:NASDAQ) shot up at $0.76, a gain of 97.9%. On Thu, Aug 01, 2024, RDHL:NASDAQ hit a New 2-Week High of $0.76. The stock got featured on our News Catalysts scanner on Thu, Aug 01, 2024 at 07:53 AM in the 'BIOTECH' category. From Thu, Jul 18, 2024, the stock recorded 40.00% Up Days and 54.55% Green Days
About RedHill Biopharma Ltd. (RDHL:NASDAQ)
RedHill Biopharma Ltd is a specialty biopharmaceutical company engaged in the development and commercialization of late clinical-stage, proprietary, and small molecule drugs for the treatment of gastrointestinal and inflammatory diseases and cancer.
Top 10 Gainers:
- RedHill Biopharma Ltd. (RDHL:NASDAQ), 97.87%
- NextPlay Technologies Inc. (NXTP:NASDAQ), 76.92%
- Dermata Therapeutics Inc. (DRMA:NASDAQ), 44.19%
- American Well Corporation Class A (AMWL:NYSE), 40.2%
- Next Technology Holding Inc. (NXTT:NASDAQ), 38.13%
- Agape ATP Corporation (ATPC:NASDAQ), 36.21%
- Omnicell, Inc. (OMCL:NASDAQ), 33%
- Sacks Parente Golf Inc. (SPGC:NASDAQ), 30.23%
- Exact Sciences Corporation (EXAS:NASDAQ), 26.77%
- Armada Acquisition Corp. I (AACI:NASDAQ), 25.3%